DVAX - Dynavax Technologies Corporation

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue11,0434,05011,032
Cost of Revenue---
Gross Profit11,0434,05011,032
Operating Expenses
Research Development84,49386,94384,580
Selling General and Administrative37,25722,18017,763
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-110,707-105,073-91,311
Income from Continuing Operations
Total Other Income/Expenses Net-1,737-1,149624
Earnings Before Interest and Taxes-112,444-104,551-90,687
Interest Expense-57235
Income Before Tax-112,444-105,123-90,722
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-112,444-106,794-90,722
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-112,444-106,794-90,722
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-112,444-106,794-90,722